Apyx Medical Corporation (APYX) Q1 2026 Earnings Call Transcript
Apyx Medical (APYX) came out with a quarterly loss of $0.05 per share versus the Zacks Consensus Estimate of a loss of $0.11. This compares to a loss of $0.1 per share a year ago.
Apyx Medical Corporation (APYX) Q4 2025 Earnings Call Transcript
| Health Care Equipment & Supplies Industry | Healthcare Sector | Charles D. Goodwin CEO | XDUS Exchange | US03837C1062 ISIN |
| US Country | 220 Employees | - Last Dividend | - Last Split | - IPO Date |
Apyx Medical Corporation stands at the forefront of energy technology within the medical device industry, both in the United States and on an international scale. The company has carved a niche for itself through the design, development, and manufacturing of advanced medical devices. It operates across two main segments: Advanced Energy and Original Equipment Manufacturing (OEM). Initially known as Bovie Medical Corporation, it underwent a rebranding phase to become Apyx Medical Corporation in January 2019. This rebranding marked a significant milestone in the company's evolution since its inception in 1982. Headquartered in Clearwater, Florida, Apyx has continuously expanded its footprint in the medical technology space, underscoring its commitment to innovation and quality healthcare solutions.
The flagship technology of Apyx Medical Corporation, the Helium Plasma Generator, revolutionizes the delivery of RF energy and helium plasma. It's meticulously designed for cutting, coagulating, and ablating soft tissue in both open and minimally invasive surgical procedures. This advanced equipment signifies the company's innovative prowess in medical device engineering.
Under the umbrella of Helium Plasma Technology, Apyx markets its products for different markets under two brands: Renuvion and J-Plasma. Renuvion caters to the cosmetic surgery market, providing state-of-the-art equipment for aesthetic enhancements. Meanwhile, J-Plasma is targeted towards the hospital surgical market, where precision and reliability are paramount. This strategic segmentation allows Apyx to address the unique needs of different market sectors effectively.
Apyx doesn't just serve end-users directly; it also engages in the development and manufacturing of OEM generators and related accessories. This segment of their business underscores Apyx's versatility and deep understanding of the medical device landscape. Providing OEM solutions, Apyx showcases its ability to innovate not just for its product line but for other companies seeking to integrate Apyx’s advanced energy solutions into their offerings.
Complementing its range of generators, Apyx also specializes in the creation of various hand pieces designed for a wide array of surgical applications, both open and laparoscopic. These hand pieces are a testament to the company’s commitment to offering comprehensive solutions that enhance surgical efficiency and outcomes.